| Literature DB >> 32314951 |
Traci C Green1,2, Jeffrey Bratberg3, Deborah S Finnell4.
Abstract
We highlight the critical roles that pharmacists have related to sustaining and advancing the changes being made in the face of the current COVID-19 pandemic to ensure that patients have more seamless and less complex access to treatment. Discussed herein is how the current COVID-19 pandemic is impacting persons with substance use disorders, barriers that persist, and the opportunities that arise as regulations around treatments for this population are eased.Entities:
Keywords: Pandemic; buprenorphine; methadone; opioid use disorder; pharmacists; policy; regulations
Mesh:
Substances:
Year: 2020 PMID: 32314951 DOI: 10.1080/08897077.2020.1752351
Source DB: PubMed Journal: Subst Abus ISSN: 0889-7077 Impact factor: 3.716